MFBTD
ARIA

MB Financial Bank - Trust Department’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

MB Financial Bank - Trust Department’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-500
Closed -$4K – 673
2015
Q1 		$4K Buy
+500
New +$3.7K ﹤0.01% 395

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

MB Financial Bank - Trust Department's ARIA Position: Q2 2015 in Review

MB Financial Bank - Trust Department sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2015, closing a stake of 500 shares — an estimated $4K sold.

MB Financial Bank - Trust Department first reported a position in ARIA in Q1 2015 and held it in 1 quarter. The position peaked at $4K in Q1 2015. 177 funds tracked by Wall St. Rank hold ARIA as of Q2 2015.

  • MB Financial Bank - Trust Department reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • MB Financial Bank - Trust Department sold 500 Ariad Pharmaceuticals Inc shares in Q2 2015, an estimated $4K.
  • MB Financial Bank - Trust Department first reported a position in Ariad Pharmaceuticals Inc in Q1 2015 and held it in 1 quarter.
  • MB Financial Bank - Trust Department's Ariad Pharmaceuticals Inc position peaked at $4K in Q1 2015.
  • 177 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2015.

Based on MB Financial Bank - Trust Department's 13F filing for Q2 2015, filed 15 Jul 2015.